These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 36135072
1. Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity. Tsukamoto S, Mavrogenis AF, Hindiskere S, Honoki K, Kido A, Fujii H, Masunaga T, Tanaka Y, Chinder PS, Donati DM, Errani C. Curr Oncol; 2022 Sep 05; 29(9):6383-6399. PubMed ID: 36135072 [Abstract] [Full Text] [Related]
2. Does Osteoarticular Allograft Reconstruction Achieve Long-term Survivorship after En Bloc Resection of Grade 3 Giant Cell Tumor of Bone? Albergo JI, Farfalli GL, Cabas-Geat A, Roitman P, Ayerza MA, Aponte-Tinao LA. Clin Orthop Relat Res; 2020 Nov 05; 478(11):2562-2570. PubMed ID: 32469488 [Abstract] [Full Text] [Related]
4. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation. Tsukamoto S, Hindiskere S, Honoki K, Mavrogenis AF, Tanaka Y, Chinder PS, Donati DM, Errani C. Int Orthop; 2023 Jan 05; 47(1):265-273. PubMed ID: 36282294 [Abstract] [Full Text] [Related]
6. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study. Takeuchi A, Tsuchiya H, Ishii T, Nishida Y, Abe S, Matsumine A, Kawai A, Yoshimura K, Ueda T. BMC Musculoskelet Disord; 2016 Jul 22; 17():306. PubMed ID: 27448567 [Abstract] [Full Text] [Related]
7. Recurrent giant cell tumour of the distal ulna after en bloc resection with preoperative denosumab use. Fujihara N, Hamada S, Yoshida M, Tsukushi S. BMJ Case Rep; 2021 Nov 11; 14(11):. PubMed ID: 34764115 [Abstract] [Full Text] [Related]
8. Giant cell tumors of the distal ulna: long-term recurrence rate and functional outcomes of en bloc resection versus curettage in a multicenter study. Zhou L, Tang J, Shen L, Zhang Z, Yuan T. J Orthop Surg Res; 2023 Sep 30; 18(1):743. PubMed ID: 37777754 [Abstract] [Full Text] [Related]
9. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 30; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
10. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture]. Li X, Guo W, Yang Y, Wei R, DU ZY. Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct 18; 45(5):745-51. PubMed ID: 24136271 [Abstract] [Full Text] [Related]
11. [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna]. Mahdal M, Jindra J, Staniczková Zambo I, Pazourek L, Nachtnebl L, Tomáš T. Acta Chir Orthop Traumatol Cech; 2022 Oct 18; 89(3):188-192. PubMed ID: 35815484 [Abstract] [Full Text] [Related]
12. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study. Ke J, Cheng S, Yao MY, Chu X, Wang M, Zeng XL, Yang T, Zhang C, Zhong H, Zhang Y. Orthop Surg; 2021 Feb 18; 13(1):185-195. PubMed ID: 33442922 [Abstract] [Full Text] [Related]
13. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors? Farfalli GL, Albergo JI, Piuzzi NS, Ayerza MA, Muscolo DL, Ritacco LE, Aponte-Tinao LA. Clin Orthop Relat Res; 2018 Mar 18; 476(3):511-517. PubMed ID: 29529633 [Abstract] [Full Text] [Related]
14. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture. Medellin MR, Fujiwara T, Tillman RM, Jeys LM, Gregory J, Stevenson JD, Parry M, Abudu A. Bone Joint J; 2018 Dec 18; 100-B(12):1626-1632. PubMed ID: 30499317 [Abstract] [Full Text] [Related]
15. Denosumab Does Not Decrease Local Recurrence in Giant Cell Tumor of Bone Treated With En Bloc Resection. Tsukamoto S, Mavrogenis AF, Tanaka Y, Kido A, Kawaguchi M, Errani C. Orthopedics; 2021 Dec 18; 44(6):326-332. PubMed ID: 34618637 [Abstract] [Full Text] [Related]
16. Management of giant cell tumors of the distal radius: a systematic review and meta-analysis. Koucheki R, Gazendam A, Perera J, Griffin A, Ferguson P, Wunder J, Tsoi K. Eur J Orthop Surg Traumatol; 2023 May 18; 33(4):759-772. PubMed ID: 35377078 [Abstract] [Full Text] [Related]
17. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone? Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS. Clin Orthop Relat Res; 2020 Nov 18; 478(11):2522-2533. PubMed ID: 32401001 [Abstract] [Full Text] [Related]
18. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint. Duan DK, Zhang GC, Sun BJ, Ma TX, Zhao M. Eur Rev Med Pharmacol Sci; 2023 Jun 18; 27(11):5039-5052. PubMed ID: 37318478 [Abstract] [Full Text] [Related]
19. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report. Tang Q, Lu J, Zhu X, Song G, Wu H, Xu H, Wang A, Wang J. Eur Spine J; 2023 Dec 18; 32(12):4297-4305. PubMed ID: 37318598 [Abstract] [Full Text] [Related]